nach oben

Drug Safety

Erschienen in:

01.04.2013 | Commentary

Systematic Collection of Patient-Reported Adverse Drug Reactions: A Path to Patient-Centred Pharmacovigilance

verfasst von: Ethan Basch

Erschienen in: Drug Safety | Ausgabe 4/2013

Einloggen, um Zugang zu erhalten

Excerpt

Over the past 15 years, evidence has mounted that patient self-reporting of symptomatic adverse drug reactions is both feasible and informative. Multiple recent reports have described programmes internationally in which patient self-reports provide data beyond reporting by health professionals [1‐5]. Various models have been used and there are several essential lessons to be learned from these experiences, in addition to work using patient-reported data in related contexts such as clinical trials and routine clinical practice. …

van Hunsel F, Härmark L, Pal S, Olsson S, van Grootheest K. Experiences with adverse drug reaction reporting by patients: an 11-country survey. Drug Saf. 2012;35(1):45–60.PubMedCrossRef

Avery AJ, Anderson C, Bond CM, Fortnum H, Gifford A, Hannaford PC, et al. Evaluation of patient reporting of adverse drug reactions to the UK ‘Yellow Card Scheme’: literature review, descriptive and qualitative analyses, and questionnaire surveys. Health Technol Assess. 2011;15(20):1–234, iii–iv.

Anderson C, Krska J, Murphy E, Avery A, Yellow Card Study Collaboration. The importance of direct patient reporting of suspected adverse drug reactions: a patient perspective. Br J Clin Pharmacol. 2011;72(5):806–22.PubMedCrossRef

Inch J, Watson MC, Anakwe-Umeh S. Patient versus healthcare professional spontaneous adverse drug reaction reporting: a systematic review. Drug Saf. 2012;35(10):807–18.PubMed

de Langen J, van Hunsel F, Passier A, de Jong-van den Berg L, van Grootheest K. Adverse drug reaction reporting by patients in the Netherlands: three years of experience. Drug Saf. 2008;31(6):515–24.PubMedCrossRef

Du D, Goldsmith J, Aikin KJ, Encinosa WE, Nardinelli C. Despite 2007 law requiring FDA hotline to be included in print drug ads, reporting of adverse events by consumers still low. Health Aff (Millwood). 2012;31(5):1022–9.

Leone R, Moretti U, D’Incau P, Conforti A, Magro L, Lora R, et al. Effect of pharmacist involvement on patient reporting of adverse drug reactions: first Italian study. Drug Saf. 2013;36(4). doi:10.1007/s40264-013-0028-8.

Methodology Committee of the Patient-Centered Outcomes Research Institute (PCORI). Methodological standards and patient-centeredness in comparative effectiveness research: the PCORI perspective. JAMA. 2012;307(15):1636–40.

Titel: Systematic Collection of Patient-Reported Adverse Drug Reactions: A Path to Patient-Centred Pharmacovigilance
verfasst von: Ethan Basch
Publikationsdatum: 01.04.2013
Verlag: Springer International Publishing AG
Erschienen in: Drug Safety / Ausgabe 4/2013
Print ISSN: 0114-5916
Elektronische ISSN: 1179-1942
DOI: https://doi.org/10.1007/s40264-013-0026-x

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 4/2013

Does Melatonin Affect Epileptic Seizures?

Effect of Pharmacist Involvement on Patient Reporting of Adverse Drug Reactions: First Italian Study

Safety Profile of Modafinil Across a Range of Prescribing Indications, Including Off-Label Use, in a Primary Care Setting in England

Comparative Performance of Two Drug Interaction Screening Programmes Analysing a Cross-Sectional Prescription Dataset of 84,625 Psychiatric Inpatients

Incidence of Adverse Events Among Healthcare Workers Following H1N1 Mass Immunization in Ghana

Inhaled Corticosteroids and the Occurrence of Oral Candidiasis: A Prescription Sequence Symmetry Analysis